Concepedia

John M. Errico

JM

22

Publications

3.9K

Citations

19

H-Index

1962

Active since

Affiliations

Washington University in St. Louis(Current)

Vanderbilt University Medical Center

Vir Biotechnology (Switzerland)

VIR Biotechnology (United States)

University of Wisconsin–Madison

John M. Errico is an author at Washington University in St. Louis specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

1962–2024

22

Publications

22

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen, Xianwen Zhang, James Brett Case et al. · Nature Medicine · 2021 · 1K citations · Full text

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet et al. · Cell Host & Microbe · 2021 · 841 citations · Full text

, , +5

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Laura A. VanBlargan, John M. Errico, Peter Halfmann et al. · Nature Medicine · 2022 · 758 citations · Full text

, , +7

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Rita E. Chen, Emma S. Winkler, James Brett Case et al. · Nature · 2021 · 260 citations · Full text

, , +2

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

James Brett Case, Samantha Mackin, John M. Errico et al. · Nature Communications · 2022 · 151 citations · Full text

Rows per page

1–5 of 22